Siu et al.[59] investigated the function of NANOG in ovarian tumorigenesis and found that overexpression of NANOG in the nucleus is significantly associated with high-grade serous ovarian cancer, increased chemoresistance, and poorer overall and disease-free survival of patients. The gene discussed is NANOG; the disease is ovarian serous adenocarcinoma.